EXHIBIT 99.1

              MEDICARE CLARIFICATION REIMBURSING THE FREEDOM60 WITH
                          SUBCUTANEOUS IMMUNE GLOBULIN

CHESTER, N.Y., September 4, 2007 -- According to a guidance document from
Medicare's Region B contracting agent, the Freedom60, manufactured by Repro-Med
Systems (REPR.OB) dba RMS Medical Products in Chester New York, is the only
infusion pump to be reimbursed for use with subcutaneous immune globulin.

"The Freedom 60 Syringe Infusion Pump is the only allowable pump to be billed
with the Subcutaneous Immune Globulin (SCIG)," states the guidance document
released in June 2007. This notification goes on to say, "All other pumps or
modifiers will result in a denial." The document may be viewed in its entirety
at:

http://www.adminastar.com/Providers/DMERC/MedicalReview/files/ClarificationonExt
ernalInfusionPumpswithSubcutaneous.pdf

Subcutaneous immune globulin is used to treat a medical condition called Primary
Immune deficiency (PI), usually considered to be genetic group of disorders
currently affecting an estimated 50,000 Americans. These disorders compromise
the immune system, leaving patients vulnerable to recurrent, life- threatening
infections. Immune globulin is a life-sustaining blood product that has become a
standard replacement therapy for most people diagnosed with PI, with nearly 70%
of PI patients receiving some form of IgG replacement therapy.

The Freedom60 Syringe Infusion Pump is the preferred system for the
administration of immune globulin due to its safe, controlled pressure and
ability to automatically adjust the flow rate to meet the needs of the patient.
This inherently safe design minimizes pain, swelling and other complications
caused by the use of conventional electric infusion devices. "The reality is
that not only does the Freedom60 have the most effective technology to
administer various medications at the lowest cost per dose, but for IgG, it is
the safest, it results in the least side effects, it is the lowest cost device
on the market, and it is the only product that is reimbursed by Medicare for
SCIG," commented Andy Sealfon, President of Repro- Med Systems. "Why would
anyone use something else?"

For many uses, the Freedom60 offers a portable, high quality, non- electric,
maintenance free delivery system for ambulatory, home and hospital use,
delivering precise infusion rates and uniform flow profiles that provide
consistent transfer of medication. The Freedom60 is a versatile, easy-to-use
lightweight mechanical pump providing a cost-effective alternative to expensive
electronic and disposable IV administration devices and may be used to deliver a
wide range of infusion products including antibiotics, pain control,
chemotherapy drugs, desferal, and cardiac drugs, among others.

Forward Looking Statements

Statements in this press release may contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. All
statements, other than statements of historical facts, may be forward- looking
statements. These statements are based on management's current expectations and
are subject to uncertainty and changes in circumstances. These statements
involve risks and uncertainties that could cause actual results to differ
materially from those included in forward-looking statements due to a variety of
factors. More information about these factors can be found in Repro-Med's latest
Annual Report filed with Securities and Exchange Commission on Form 10-KSB. The
company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

Andy Sealfon
1-800-624-9600 x 307
RMS Medical Products
24 Carpenter Road
Chester, New York 10918                Visit our web site at:  www.Freedom60.com